Examination of a blood-brain barrier targeting β-galactosidase-monoclonal antibody fusion protein in a murine model of GM1-gangliosidosis-Reference-Cited by-同舟云学术

Examination of a blood-brain barrier targeting β-galactosidase-monoclonal antibody fusion protein in a murine model of GM1-gangliosidosis

Published:2021-06 Issue: Volume:27 Page:100748
ISSN:2214-4269
Container-title:Molecular Genetics and Metabolism Reports
language:en
Short-container-title:Molecular Genetics and Metabolism Reports

Author:

Przybilla Michael J.,Stewart Christine,Carlson Timothy W.,Ou Li,Koniar Brenda L.,Sidhu Rohini,Kell Pamela J.,Jiang Xuntian,Jarnes Jeanine R.,O'Sullivan M. Gerard,Whitley Chester B.

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology

Reference35 articles.

1. Beta-galactosidase deficiency (beta-galactosidosis): GM1 gangliosidosis and Morquio B disease;Suzuki,2001

2. Infantile gangliosidoses: mapping a timeline of clinical changes;Jarnes Utz;Mol. Genet. Metab.,2017

3. The juvenile gangliosidoses: A timeline of clinical change;King;Mol. Genet. Metab. Rep.,2020

4. Enzyme replacement for lysosomal diseases;Brady;Annu. Rev. Med.,2006

5. Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges;Desnick;Annu. Rev. Genomics Hum. Genet.,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic developments for neurodegenerative GM1 gangliosidosis;Frontiers in Neuroscience;2024-04-26

2. Glycosphingolipids and central nervous system–related diseases;Glycosphingolipids in the Central Nervous System;2024

3. Gene therapy approaches for GM1 gangliosidosis: Focus on animal and cellular studies;Cell Biochemistry and Function;2023-11-29

4. Molecular Trojan Horses for treating lysosomal storage diseases;Molecular Genetics and Metabolism;2023-11

5. Ganglioside GM1 and the Central Nervous System;International Journal of Molecular Sciences;2023-05-31